BIOMAT Database Logo BIOMAT Database Logo

Thromboplastin activity in amniotic fluid. 1985

I H Omsjø, and P Oian, and J M Maltau, and B Osterud

Thromboplastin activity in amniotic fluid from 39 patients pregnant in weeks 14-40 has been studied. Amniotic fluid was obtained by amniocentesis. All fluids were fractionated and the activity studied in both supernatant and sediment in a highly specific and sensitive test system. All samples tested showed a very high thromboplastin activity. No correlation to gestational age was found. Amniotic samples from 19 of the patients were incubated with endotoxin. Endotoxin did not further increase the procoagulant activity.

UI MeSH Term Description Entries
D011225 Pre-Eclampsia A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease. Toxemias, Pregnancy,EPH Complex,EPH Gestosis,EPH Toxemias,Edema-Proteinuria-Hypertension Gestosis,Gestosis, EPH,Hypertension-Edema-Proteinuria Gestosis,Preeclampsia,Preeclampsia Eclampsia 1,Pregnancy Toxemias,Proteinuria-Edema-Hypertension Gestosis,Toxemia Of Pregnancy,1, Preeclampsia Eclampsia,1s, Preeclampsia Eclampsia,EPH Toxemia,Eclampsia 1, Preeclampsia,Eclampsia 1s, Preeclampsia,Edema Proteinuria Hypertension Gestosis,Gestosis, Edema-Proteinuria-Hypertension,Gestosis, Hypertension-Edema-Proteinuria,Gestosis, Proteinuria-Edema-Hypertension,Hypertension Edema Proteinuria Gestosis,Of Pregnancies, Toxemia,Of Pregnancy, Toxemia,Pre Eclampsia,Preeclampsia Eclampsia 1s,Pregnancies, Toxemia Of,Pregnancy Toxemia,Pregnancy, Toxemia Of,Proteinuria Edema Hypertension Gestosis,Toxemia Of Pregnancies,Toxemia, EPH,Toxemia, Pregnancy,Toxemias, EPH
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D004731 Endotoxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. Endotoxin
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000653 Amniotic Fluid A clear, yellowish liquid that envelopes the FETUS inside the sac of AMNION. In the first trimester, it is likely a transudate of maternal or fetal plasma. In the second trimester, amniotic fluid derives primarily from fetal lung and kidney. Cells or substances in this fluid can be removed for prenatal diagnostic tests (AMNIOCENTESIS). Amniotic Fluid Index,Amniotic Fluid Indices,Amniotic Fluids,Fluid Index, Amniotic,Fluid Indices, Amniotic,Fluid, Amniotic,Fluids, Amniotic,Index, Amniotic Fluid,Indices, Amniotic Fluid
D013925 Thromboplastin Constituent composed of protein and phospholipid that is widely distributed in many tissues. It serves as a cofactor with factor VIIa to activate factor X in the extrinsic pathway of blood coagulation. Antigens, CD142,CD142 Antigens,Coagulation Factor III,Factor III,Tissue Factor,Tissue Thromboplastin,Blood Coagulation Factor III,Coagulin,Glomerular Procoagulant Activity,Prothrombinase,Tissue Factor Procoagulant,Urothromboplastin,Activity, Glomerular Procoagulant,Factor III, Coagulation,Procoagulant Activity, Glomerular,Procoagulant, Tissue Factor,Thromboplastin, Tissue

Related Publications

I H Omsjø, and P Oian, and J M Maltau, and B Osterud
[Thromboplastin activity of amniotic fluid].
January 1953, Minerva ginecologica,
I H Omsjø, and P Oian, and J M Maltau, and B Osterud
[Thromboplastin content in amniotic fluid and its clinical significance].
October 1960, Nordisk medicin,
I H Omsjø, and P Oian, and J M Maltau, and B Osterud
Tumor fluid thromboplastin activity.
September 1968, International journal of cancer,
I H Omsjø, and P Oian, and J M Maltau, and B Osterud
[Thromboplastin activity of the amniotic fluid as a criterion of fetal maturity in normal pregnancy].
January 1984, Akusherstvo i ginekologiia,
I H Omsjø, and P Oian, and J M Maltau, and B Osterud
[Procoagulant properties of the amniotic fluid. IV. The acceleration time of thromboplastin in the amniotic fluid in pathologic pregnancy].
June 1989, Ginecologia y obstetricia de Mexico,
I H Omsjø, and P Oian, and J M Maltau, and B Osterud
[Procoagulant properties of the amniotic fluid. II. Thromboplastin acceleration in the amniotic fluid in the diagnosis of prolonged pregnancy].
November 1986, Ginecologia y obstetricia de Mexico,
I H Omsjø, and P Oian, and J M Maltau, and B Osterud
[Procoagulant properties of the amniotic fluid I. Thromboplastin acceleration time in amniotic fluid throughout normal pregnancies. Its clinical perspectives].
October 1986, Ginecologia y obstetricia de Mexico,
I H Omsjø, and P Oian, and J M Maltau, and B Osterud
Antitryptic activity in amniotic fluid.
October 1981, Clinical chemistry,
I H Omsjø, and P Oian, and J M Maltau, and B Osterud
[Measurement of the thromboplastin activity of the amniotic fluid as an index of gestational age in normal pregnancies].
January 1984, Revista chilena de obstetricia y ginecologia,
I H Omsjø, and P Oian, and J M Maltau, and B Osterud
Argininosuccinase activity in amniotic-fluid cells.
July 1970, Lancet (London, England),
Copied contents to your clipboard!